SCHEMBL8683247

SCHEMBL8683247

CCCC(CC)OC(=O)OC1CCC[N]1

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 1/20 0.34
PRKCD Q05655 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8707805 0.96 PRKCA (0.33) PRKCAPRKCD
SCHEMBL8683116 0.92 EPHX2 (0.36) PRKCAPRKCD
SCHEMBL8682177 0.91
SCHEMBL8686123 0.91 EPHX2 (0.34) PRKCAPRKCD
SCHEMBL8681205 0.89 NAAA (0.35) PRKCAPRKCD
SCHEMBL8680824 0.89 NAAA (0.35) PRKCAPRKCD
SCHEMBL8681243 0.89 NAAA (0.35) PRKCAPRKCD
SCHEMBL8683157 0.89 NAAA (0.35) PRKCAPRKCD
SCHEMBL8683170 0.89 NAAA (0.35) PRKCAPRKCD
SCHEMBL8681042 0.89 NAAA (0.35) PRKCAPRKCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5843983-A Diphenylethane compounds containing a saturated heterocyclic group, their preparation, and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1998-12-01 US disclosed
EP-0844000-A1 Use of alpha, omega-diarylalkane derivatives in the treatment and prevention of psychosis SANKYO COMPANY LIMITED (JP) 1998-05-27 EP disclosed
EP-0790235-A1 Diaryl alkane derivatives containing an alicyclic group, their preparation and their therapeutic and prophylactic uses SANKYO COMPANY LIMITED (JP) 1997-08-20 EP disclosed
US-5556864-A TREATMENT OF CIRCULATORY DISEASES AND PSYCHOSIS SANKYO COMPANY, LIMITED (JP) 1996-09-17 US disclosed
EP-0600717-A1 Phenoxyalkylamines, -pyrrolidines and -piperidines for the treatment and prevention of circulatory diseases and psychosis SANKYO COMPANY LIMITED (JP) 1994-06-08 EP disclosed